Roles of α1- and α2-adrenoceptors in the nucleus raphe magnus in opioid analgesia and opioid abstinence-induced hyperalgesia

Journal of Neuroscience

Volumn 23, Issue 21, 2003, Pages 7950-7957

  Bie, B ^a   Fields, H L ^b   Williams, J T ^c   Pan, Z Z ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Analgesia; Hyperalgesia; Nucleus raphe magnus; Opioid; Pain; 1 adrenoceptors; 2 adrenoceptors

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR; ANALGESIC AGENT; NORADRENALIN; OPIATE; POTASSIUM; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; MU OPIATE RECEPTOR; NARCOTIC ANALGESIC AGENT; POTASSIUM CHANNEL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DRUG WITHDRAWAL; HYPERALGESIA; MALE; NERVE CONDUCTION; NOCICEPTION; NONHUMAN; PAIN; PRIORITY JOURNAL; RAPHE MAGNUS NUCLEUS; RAT; RECEPTOR INTRINSIC ACTIVITY; SPINAL NERVE; SYNAPTIC TRANSMISSION; ACTION POTENTIAL; ANIMAL; BIOLOGICAL MODEL; CELL CULTURE; CHEMISTRY; CYTOLOGY; DRUG EFFECT; DRUG POTENTIATION; ELECTRIC CONDUCTIVITY; NERVE CELL; PATCH CLAMP; PHYSIOLOGY; RAPHE NUCLEUS; WISTAR RAT;

ACTION POTENTIALS; ANALGESICS, OPIOID; ANIMALS; CELLS, CULTURED; ELECTRIC CONDUCTIVITY; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; HYPERALGESIA; MALE; MODELS, NEUROLOGICAL; NEURONS; NOREPINEPHRINE; PATCH-CLAMP TECHNIQUES; POTASSIUM CHANNELS; RAPHE NUCLEI; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, ALPHA-1; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, OPIOID, MU;

EID: 0042283881     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.23-21-07950.2003     Document Type: Article

References (33)

1. Arima J, Kubo C, Ishibashi H, Akaike N (1998) alpha2-Adrenoceptor-mediated potassium currents in acutely dissociated rat locus coeruleus neurones. J Physiol (Lond) 508:57-66.
2. Bai D, Renaud LP (1998) Median preoptic nucleus neurons: an in vitro patch-clamp analysis of their intrinsic properties and noradrenergic receptors in the rat. Neuroscience 83:905-916.
3. Basbaum A (1992) Anatomical studies of the noradrenergic projections to the spinal cord dorsal horn. In: Towards the use of noradrenergic agonists for the treatment of pai (Besson J, Guilbaud G, eds), pp 77-89. Amsterdam: Excerpta Medica.
4. Bederson JB, Fields HL, Barbaro NM (1990) Hyperalgesia during naloxone-precipitated withdrawal from morphine is associated with increased on-cell activity in the rostral ventromedial medulla. Somatosens Mot Res 7:185-203.
5. Bellchambers CE, Chieng B, Keay KA, Christie MJ (1998) Swim-stress but not opioid withdrawal increases expression of c-fos immunoreactivity in rat periaqueductal gray neurons which project to the rostral ventromedial medulla. Neuroscience 83:517-524.
6. Burnett A, Gebhart GF (1991) Characterization of descending modulation of nociception from the A5 cell group. Brain Res 546:271-281.
7. Christie MJ, Williams JT, Osborne PB, Bellchambers CE (1997) Where is the locus in opioid withdrawal? Trends Pharmacol Sci 18:134-140.
8. Delfs JM, Zhu Y, Druhan JP, Aston-Jones G (2000) Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion. Nature 403:430-434.
9. Fields H, Basbaum A (1999) Central nervous system mechanisms of pain modulation. In: Textbook of pain, Ed 4 (Wall P, Melzack R, eds). London: Churchill Livingstone.
10. Galeotti N, Ghelardini C, Vinci MC, Bartolini A (1999) Role of potassium channels in the antinociception induced by agonists of alpha2-adrenoceptors. Br J Pharmacol 126:1214-1220.
11. Grudt TJ, Williams JT, Travagli RA (1995) Inhibition by 5-hydroxytryptamine and noradrenaline in substantia gelatinosa of guinea-pig spinal trigeminal nucleus. J Physiol (Lond) 485:113-120.
12. Haws CM, Heinricher MM, Fields HL (1990) Alpha-adrenergic receptor agonists, but not antagonists, alter the tail-flick latency when microinjected into the rostral ventromedial medulla of the lightly anesthetized rat. Brain Res 533:192-195.
13. Heishman SJ, Stitzer ML, Bigelow GE, Liebson IA (1989) Acute opioid physical dependence in postaddict humans: naloxone dose effects after brief morphine exposure. J Pharmacol Exp Ther 248:127-134.
14. Holden JE, Schwartz EJ, Proudfit HK (1999) Microinjection of morphine in the A7 catecholamine cell group produces opposing effects on nociception that are mediated by alpha1- and alpha2-adrenoceptors. Neuroscience 91:979-990.
15. Kaplan H, Fields H (1991) Hyperalgesia during acute opioid abstinence: evidence for a nociceptive facilitating function of the rostral ventromedial medulla. J Neurosci 11:1433-1439.
16. Larkman PM, Kelly JS (1992) Ionic mechanisms mediating 5-hydroxytryptamineand noradrenaline-evoked depolarization of adult rat facial motoneurones. J Physiol (Lond) 456:473-490.
17. Maldonado R (1997) Participation of noradrenergic pathways in the expression of opiate withdrawal: biochemical and pharmacological evidence. Neurosci Biobehav Rev 21:91-104.
18. McCormick DA (1992) Cellular mechanisms underlying cholinergic and noradrenergic modulation of neuronal firing mode in the cat and guinea pig dorsal lateral geniculate nucleus. J Neurosci 12:278-289.
19. McNally GP, Akil H (2002) Role of corticotropin-releasing hormone in the amygdala and bed nucleus of the stria terminalis in the behavioral, pain modulatory, and endocrine consequences of opiate withdrawal. Neuroscience 112:605-617.
20. Meng XW, Budra B, Skinner K, Ohara PT, Fields HL (1997) Noradrenergic input to nociceptive modulatory neurons in the rat rostral ventromedial medulla. J Comp Neurol 377:381-391.
21. Nuseir K, Proudfit HK (2000) Bidirectional modulation of nociception by GABA neurons in the dorsolateral pontine tegmentum that tonically inhibit spinally projecting noradrenergic A7 neurons. Neuroscience 96:773-783.
22. Nuseir K, Heidenreich BA, Proudfit HK (1999) The antinociception produced by microinjection of a cholinergic agonist in the ventromedial medulla is mediated by noradrenergic neurons in the A7 catecholamine cell group. Brain Res 822:1-7.
23. Pan Z, Hirakawa N, Fields HL (2000) A cellular mechanism for the bidirectional pain-modulating actions of orphanin FQ/nociceptin. Neuron 26:515-522.
24. Pan ZZ, Williams JT, Osborne PB (1990) Opioid actions on single nucleus raphe magnus neurons from rat and guinea-pig in vitro. J Physiol (Lond) 427:519-532.
25. Pan ZZ, Grudt TJ, Williams JT (1994) Alpha 1-adrenoceptors in rat dorsal raphe neurons: regulation of two potassium conductances. J Physiol (Lond) 478:437-447.
26. Pan ZZ, Tershner SA, Fields HL (1997) Cellular mechanism for antianalgesic action of agonists of the kappa-opioid receptor. Nature 389:382-385.
27. Porreca F, Burgess SE, Gardell LR, Vanderah TW, Malan Jr TP, Ossipov MH, Lappi DA, Lai J (2001) Inhibition of neuropathic pain by selective ablation of brainstem medullary cells expressing the μ-opioid receptor. J Neurosci 21:5281-5288.
28. Porreca F, Ossipov MH, Gebhart GF (2002) Chronic pain and medullary descending facilitation. Trends Neurosci 25:319-325.
29. Pralong E, Magistretti PJ (1995) Noradrenaline increases K-conductance and reduces glutamatergic transmission in the mouse entorhinal cortex by activation of alpha 2-adrenoreceptors. Eur J Neurosci 7:2370-2378.
30. Proudfit HK (1988) Pharmacologic evidence for the modulation of nociception by noradrenergic neurons. Prog Brain Res 77:357-370.
31. Raghavendra V, Rutkowski MD, DeLeo JA (2002) The role of spinal neuroimmune activation in morphine tolerance/hyperalgesia in neuropathic and sham-operated rats. J Neurosci 22:9980-9989.
32. Raja SN (1995) Role of the sympathetic nervous system in acute pain and inflammation. Ann Med 27:241-246.
33. Tanaka M, Matsumoto Y, Murakami T, Hisa Y, Ibata Y (1996) The origins of catecholaminergic innervation in the rostral ventromedial medulla oblongata of the rat. Neurosci Lett 207:53-56.